Olivier Brandicourt - Net Worth and Insider Trading
Olivier Brandicourt Net Worth
The estimated net worth of Olivier Brandicourt is at least $5 Million dollars as of 2024-11-13. Olivier Brandicourt is the Business Unit President of Pfizer Inc and owns about 202,260 shares of Pfizer Inc (PFE) stock worth over $5 Million. Details can be seen in Olivier Brandicourt's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Olivier Brandicourt has not made any transactions after 2013-03-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Olivier Brandicourt
Olivier Brandicourt Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Olivier Brandicourt owns 2 companies in total, including Alnylam Pharmaceuticals Inc (ALNY) , and Pfizer Inc (PFE) .
Click here to see the complete history of Olivier Brandicourt’s form 4 insider trades.
Insider Ownership Summary of Olivier Brandicourt
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals Inc | 2020-03-02 | director |
| PFE | Pfizer Inc | 2013-03-06 | Business Unit President |
Olivier Brandicourt Latest Holdings Summary
Olivier Brandicourt currently owns a total of 1 stock. Olivier Brandicourt owns 202,260 shares of Pfizer Inc (PFE) as of March 6, 2013, with a value of $5 Million.
Latest Holdings of Olivier Brandicourt
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PFE | Pfizer Inc | 2013-03-06 | 202,260 | 26.19 | 5,297,189 |
Holding Weightings of Olivier Brandicourt
Olivier Brandicourt Form 4 Trading Tracker
According to the SEC Form 4 filings, Olivier Brandicourt has made a total of 0 transactions in Pfizer Inc (PFE) over the past 5 years. The most-recent trade in Pfizer Inc is the sale of 113,364 shares on March 6, 2013, which brought Olivier Brandicourt around $3 Million.
Insider Trading History of Olivier Brandicourt
- 1
Olivier Brandicourt Trading Performance
Olivier Brandicourt Ownership Network
Ownership Network List of Olivier Brandicourt
Ownership Network Relation of Olivier Brandicourt
Olivier Brandicourt Owned Company Details
What does Alnylam Pharmaceuticals Inc do?
Who are the key executives at Alnylam Pharmaceuticals Inc?
Olivier Brandicourt is the director of Alnylam Pharmaceuticals Inc. Other key executives at Alnylam Pharmaceuticals Inc include EVP & Chief Commercial Officer Yvonne Greenstreet , EVP & Chief Commercial Officer Tolga Tanguler , and CMO & EVP Dev & Med Affairs Pushkal Garg .
Alnylam Pharmaceuticals Inc (ALNY) Insider Trades Summary
Over the past 18 months, Olivier Brandicourt made no insider transaction in Alnylam Pharmaceuticals Inc (ALNY). Other recent insider transactions involving Alnylam Pharmaceuticals Inc (ALNY) include a net sale of 52,531 shares made by Yvonne Greenstreet , a net sale of 10,304 shares made by Pushkal Garg , and a net sale of 5,639 shares made by Jeffrey V. Poulton .
In summary, during the past 3 months, insiders sold 15,000 shares of Alnylam Pharmaceuticals Inc (ALNY) in total and bought 0 shares, with a net sale of 15,000 shares. During the past 18 months, 249,128 shares of Alnylam Pharmaceuticals Inc (ALNY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 249,128 shares.
Alnylam Pharmaceuticals Inc (ALNY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alnylam Pharmaceuticals Inc Insider Transactions
Olivier Brandicourt Mailing Address
Above is the net worth, insider trading, and ownership report for Olivier Brandicourt. You might contact Olivier Brandicourt via mailing address: Pfizer Inc. Attn. Corp. Secretary, 235 East 42nd Street, New York Ny 10017.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
